The antinociceptive effect of moclobemide on the vocalization threshold to paw pressure in a rat model of unilateral mononeuropathy

Pharmacological Research

Volumn 44, Issue 6, 2001, Pages 503-507

  Apaydin, Sebnem ^a   Goldeli, Esin ^a   Uyar, Meltem ^b   Erhan, Elvan ^b   Yegul, Ibrahim ^b   Tuglular, Isik ^a  

^a EGE UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Antinociceptive effect; Moclobemide; Paw pressure; Rat; Sciatic nerve ligation

Indexed keywords

MOCLOBEMIDE;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG POTENCY; MALE; MONONEUROPATHY; NERVE LIGATION; NONHUMAN; PAIN THRESHOLD; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RAT; SCIATIC NERVE; VOCALIZATION;

EID: 0035665797     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2001.0895     Document Type: Article

References (32)

1. Analgesic activity of tricyclic antidepressant
2. The analgesic effect of tricyclic antidepressants
3. The antinociceptive effect of moclobemide in mice is mediated by noradrenergic pathways
4. Observations on the treatment of denervation dysesthesia with psychotropic drags: Postherpetic neuralgia, anesthesia dolorosa, peripheral neuropathy
5. Treatment of postherpetic neuralgia
6. Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects
7. Role of adrenoceptors in the potentiation of opioid antinociception by ephedrine and phenylpropanolamine in mice
8. Chronic tension headache treated with amitriptyline: A double blind study
9. Psychotropic drugs
10. Antidepressants in the management of chronic pain syndromes
11. Antidepressant-induced analgesia in chronic non-malignant pain: A meta-analysis of 39 placebo-controlled studies
12. Moclobemide in chronic neuropathic pain: Preliminary case reports
13. Amitriptyline potentiates morphine analgesia by direct action on the central nervous system
14. Mediation of serotonin-induced analgesia by the 5-HT receptor in the pentobarbital anaesthesized mouse model
15. A role for serotonin and β-endorphin in the analgesia induced by some tricyclic antidepressant drugs
16. The treatment of chronic pain with psychotropic drugs
17. Monoamine oxidase inhibitors
18. Drug profile: Moclobemide
19. Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression
20. Studies of reversible and selective inhibitors of monoamine oxidase A in dysthymia
21. Moclobemide: A range of opportunities
22. Selective opioid receptor agonists modulate mechanical allodynia in an animal model of neuropathic pain
23. Further evidence for a 'pain related' behaviour
24. The 'tonic' pain-related behaviour seen in mononeuropathic rats is modulated by morphine and naloxone
25. Differential effects of various doses of morphine and naloxone on two nociceptive test thresholds in arthritic and normal rats
26. Analgesic action of acute and chronic intraspinally administered opiate and alpha 2-adrenergic agonists in chronic neuropathic pain
27. Repeated low doses of morphine do not induce tolerance but increase the opioid antinociceptive effect in rats with a peripheral neuropathy
28. Antinociceptive effects of acute and 'chronic' injections of trycyclic antidepressant drugs in a new model of mononeuropathy in rats
29. Atypical facial pain and depression
30. Monoamine oxidase inhibitors in the treatment of migraine
31. Atypical odontalgia
32. Effet analgesique central d'antidepresseurs a mode d'action distinct: Desipramine, fluvoksamine et moclobemide